MARLOW, England--(BUSINESS WIRE)--Allergan, Inc. seeks to reassure patients and surgeons around the world utilizing Allergan’s breast implant devices (NATRELLE™, McGhan™ and CUI™) that its products are not part of the recent investigation into breast implant devices manufactured by French manufacturer, Poly Implant Prosthese (PIP) by regulatory authorities in Europe. It’s important to recognise that there are a number of different breast implant manufacturers around the world. The health authorities are specifically concerned about breast implants made by the company called Poly Implant Prosthese (PIP). Allergan maintains rigorous clinical development processes, extensive manufacturing and quality assurance testing, as well as an industry-leading post-marketing surveillance program, to ensure the highest quality and safety of its breast implants that patients and surgeons can rely on.
